Abstract
Purpose
The optimal method and timing of the surgical treatment for idiopathic macular holes remains unknown. The aim of this retrospective study was to identify factors associated with anatomical and visual success in macular hole surgery.
Methods
Case records of 55 patients undergoing macular hole surgery at three units in the 2-year period up to July 2002 were reviewed to identify factors associated with anatomical and visual success. The following potential prognosticators were evaluated: patient age, hole stage, hole latency prior to surgery, preoperative acuity, simultaneous phacoemulsification, and intraocular lens implantation, internal limiting membrane peeling with and/or without indocyanine green, and postoperative posturing.
Results
The duration of preoperative symptoms, indocyanine green-assisted internal limiting membrane peeling, hole stage, and better preoperative visual acuity were associated with both anatomical success and regaining a postoperative visual acuity of 6/12 or better.
Discussion
The closure rate in patients undergoing surgery within 1 year of onset was 94.0%, and in those waiting 1 year or more it was 47.4%. Clinical governance and quality issues should dictate that NHS macular hole surgery is available to all within 1 year of onset. This study showed no adverse effect of ICG dye retinal staining. The results support the use of a ‘patient-friendly’ approach of simultaneous cataract surgery with no prone postoperative posturing.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Simcock PR, Scalia S . Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol 2001; 85: 1316–1319.
Brooks Jr HL . Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000; 107: 1939–1948.
Gandorfer A, Messmer EM, Ulbig MW, Kampik A . Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 2001; 131: 387–388.
Ando F, Sasano K, Ohba N, Hirose H, Yasui O . Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004; 137: 609–614.
Haritoglou C, Gandorfer A, Gass CA, Kampik A . Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 2004; 137: 345–348.
Gandorfer A, Haritoglou C, Gandorfer A, Kampik A . Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003; 44: 316–323.
Haritoglou C, Gandorfer A, Kampik A . Indocyanine green-assisted vitreomacular surgery: adverse effects. Graefes Arch Clin Exp Ophthalmol 2003; 241: 958–990.
Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY . Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina 2003; 23: 675–681.
Ho JD, Tsai RJ, Chen SN, Chen HC . Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch Ophthalmol 2003; 121: 1423–1429.
Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A . Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002; 134: 836–841.
Johnson RN, Gass JD . Idiopathic macular holes: observations, stages of formation, and implications for surgical intervention. Ophthalmology 1998; 95: 917–924.
Thompson JT, Sjaarda RN, Lansing MB . The results of vitreous surgery for chronic macular holes. Retina 1997; 17: 493–501.
Kang HK, Chang AA, Beaumont PE . The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Exp Ophthalmol 2000; 28: 298–308.
Ben Simon GJ, Desatnik H, Alhalel A, Treister G, Moisseiev J . Retrospective analysis of vitrectomy with and without internal limiting membrane peeling for stage 3 and 4 macular hole. Ophthalmic Surg Lasers Imaging 2004; 35: 109–115.
Slaughter K, Lee IL . Macular hole surgery with and without indocyanine green assistance. Eye 2004; 18: 376–378.
Kwok AK, Lai TY, Yuen KS, Tam BS, Wong VW . Macular hole surgery with or without indocyanine green stained internal limiting membrane peeling. Clin Exp Ophthalmol 2003; 31: 470–475.
Haritoglou C, Neubauer AS, Gandorfer A, Thiel M, Kampik A . Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol 2003; 136: 389–391.
Kwok AK, Lai TY, Yew DT, Li WW . Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol 2003; 136: 223–230.
Kwok AK, Lai TY . Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case–control study. Br J Ophthalmol 2003; 87: 885–889.
Wolf S, Reichel MB, Wiedemann P, Schnurrbusch UE . Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241: 589–592.
Kwok AK, Lai TY, Man-Chan W, Woo DC . Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 2003; 87: 71–74.
Weinberger AW, Schlossmacher B, Dahlke C, Hermel M, Kirchhof B, Schrage NF . Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery—a follow-up study. Graefes Arch Clin Exp Ophthalmol 2002; 240: 913–917.
Kumar A, Prakash G, Singh RP . Indocyanine green enhanced maculorhexis in macular hole surgery. Indian J Ophthalmol 2002; 50: 123–126.
Da Mata AP, Burk SE, Riemann CD, Rosa Jr RH, Snyder ME, Petersen MR et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001; 108: 1187–1192.
Uemura A, Kanda S, Sakamoto Y, Kita H . Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2003; 136: 252–257.
Thompson JT, Glaser BM, Sjaarda RN, Murphy RP . Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995; 119: 48–54.
Lacalle VD, Garate FJO, Alday NM, Garrido JAL, Agesta JA . Phacoemulsification cataract surgery in vitrectomised eyes. J Cataract Refract Surg 1998; 24: 806–809.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented as a poster at the Royal College of Ophthalmologists Conference, Birmingham May 2003
Proprietary interests': Nil
Allocation of research funds: Nil
Rights and permissions
About this article
Cite this article
Jaycock, P., Bunce, C., Xing, W. et al. Outcomes of macular hole surgery: implications for surgical management and clinical governance. Eye 19, 879–884 (2005). https://doi.org/10.1038/sj.eye.6701679
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701679
Keywords
This article is cited by
-
Prediction of postoperative visual acuity after vitrectomy for macular hole using deep learning–based artificial intelligence
Graefe's Archive for Clinical and Experimental Ophthalmology (2022)
-
Update on surgical management of complex macular holes: a review
International Journal of Retina and Vitreous (2021)
-
Frequently assessed and used prognostic factors for outcome after macular hole surgery: which is better?
BMC Ophthalmology (2021)
-
Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort
Eye (2021)
-
Outcome of 2 cc pure sulfur hexafluoride gas tamponade for macular hole surgery
BMC Ophthalmology (2016)
